510(k) · Cleared
Recalled · Class II · 2017Dimension Vista Albumin, Alkaline Phosphatase, Aspartate Amino Transferase, Carbamazepine & Alanine Amino Transferase
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Dade Behring, Inc. · CKA Nadh Oxidation/Nad Reduction, Alt/Sgpt
Cleared on May 10, 2006 as substantially equivalent to K861700 (E.I. Dupont DE Nemours & Co., Inc., 1986) and 4 other predicates after a 27-day review. Its family tree reaches back 2 generations to 1986. It has been recalled once.
- Decided
- May 10, 2006
- Review
- 27 days
- Class
- Class I
- Product code
- CKA
- Recalls
- 1
- Predicates
- 5
Its longest line of descent runs back 2 generations to K864230 (1986). 6 ancestors in all, the oldest K860021 (1986). No later device cites it as a predicate yet.
- Root · 2 generations backK864230 Dimension (TM) Clinical Chemistry SystemE.I. Dupont DE Nemours & Co., Inc. · 1986
- 1 generation backK994115 Total Iron Binding Capacity (Ibct) Flex Reagent CartridgeDade Behring, Inc. · 2000 · Recalled
- This deviceK061020 Dimension Vista Albumin, Alkaline Phosphatase, Aspartate Amino…Dade Behring, Inc. · 2006
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K864230 | Dimension (TM) Clinical Chemistry System | E.I. Dupont DE Nemours & Co., Inc. | 1986 | — |
| −1 | K994115 | Total Iron Binding Capacity (Ibct) Flex Reagent Cartridge | Dade Behring, Inc. | 2000 | 2 |
| 0 (this device) | K061020 | Dimension Vista Albumin, Alkaline Phosphatase, Aspartate Amino Transferase… | Dade Behring, Inc. | 2006 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1986 | 3 | 0 |
| 1996 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CKA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K861700 | Dimension (TM) Clinical Chemistry SystemSummary page 1…uct Predicate 510(k) # class tion Code Dimension VistaT M Dimension® ALB ALB Flex® reagent Flex® reagent K861700 11 862.1035 CJW cartridge cartridge Dimension VistaTM Dimension® AST AST Flex®reagent F… | 1986 |
| * | K860021 | Dimension (TM) Clinical Chemistry SystemSummary page 1…reagent K861700 11 862.1035 CJW cartridge cartridge Dimension VistaTM Dimension® AST AST Flex®reagent Flex®reagent K860021 1I 862.1100 CIT cartridge cartridge Dimension VistaTM Dimension® CRBM Flex®… | 1986 |
| * | K962820 | Carbamazepine Flex Reagent CartridgeSummary page 2…860021 1I 862.1100 CIT cartridge cartridge Dimension VistaTM Dimension® CRBM Flex® reagent CRBM Flex® K962820 11 862.3645 KLT cartridge reagent cartridge Dimension VistaTM Dimension® ALT ALT Flex® r… | 1996 |
| * | K862359 | Meth./Cali./Intru. Check for the Dimension SystemSummary page 2…K962820 11 862.3645 KLT cartridge reagent cartridge Dimension VistaTM Dimension® ALT ALT Flex® reagent Flex® reagent K862359 1* 862.1030 CKA cartridge cartridge Dimension VistaTM Dimension® TIBC Flex® reagent… | 1986 |
| * | K994115 | Total Iron Binding Capacity (Ibct) Flex Reagent CartridgeSummary page 2…gent K862359 1* 862.1030 CKA cartridge cartridge Dimension VistaTM Dimension® TIBC Flex® reagent IBCT Flex® K994115 1 862.1415 IMO cartridge reagent cartridge * Not exempt when indications include diagnosis of… | 2000 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Jun 29, 2017 | Class II | Z-1657-2018 | Device Design | Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 20 years and passes through 2 companies; a new generation was cleared every 13.2 years on median.
- 4 of the 6 ancestors have a recall of any class.
- 5 other devices also cite its predicate K861700.
How does its category compare?
All CKA devicesCKA Nadh Oxidation/Nad Reduction, Alt/Sgpt: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · CKA
1in 2013
2026 to Oct 25, outlined.
Median 510(k) review, days · CKA
Too few CKA 510(k)s in any year since 2007 to give a median.
Recalls per year · CKA
1in 2016
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · CKA
8in 2025
MAUDE reports naming product code CKA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 8 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 1 | 8 |
| 2011 | 0 | — | 0 | 39 |
| 2012 | 1 | — | 0 | 8 |
| 2013 | 1 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 1 | 0 |
| 2017 | 0 | — | 0 | 2 |
| 2018 | 0 | — | 0 | 1 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 3 |
| 2021 | 0 | — | 0 | 2 |
| 2022 | 0 | — | 0 | 2 |
| 2023 | 0 | — | 0 | 4 |
| 2024 | 0 | — | 0 | 10 |
| 2025 | 0 | — | 0 | 8 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Dimension VistaTM Albumin Flex® reagent cartridge (ALB) is a device intended to mreasure the albumin concentration in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys. The Dimension VistaTM Aspartate amino transferase (AST) Flex® reagent cartridge is a device intended to measure the activity of the enzyme aspartate amino transferase (AST) in…
Read the full statement (231 words)
The Dimension VistaTM Albumin Flex® reagent cartridge (ALB) is a device intended to mreasure the albumin concentration in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys.
The Dimension VistaTM Aspartate amino transferase (AST) Flex® reagent cartridge is a device intended to measure the activity of the enzyme aspartate amino transferase (AST) in serum and plasma. Aspartate amino transferase measurements are used in the diagnosis and treatment of certain types of liver and heart disease.
The Dimension VistaTM Carbamazepine (CRBM) Flex® reagent cartridge is a device intended to measure carbamazepine, an anticonvulsant drug, in plasma and serum. Measurements obtained by this device are used in the diagnosis and treatment of carbamazepine overdose and in monitoring levels of carbamazepine to ensure appropriate therapy.
The Dimension VistaTM Alanine amino transferase (ALT) Flex® reagent cartridge is intended to measure the activity of the enzyme pyruvic transaminase (ALT) in serum and plasma. Alanine amino transferase measurements are used in the diagnosis and treatment of certain liver diseases (e.g. viral hepatitis and cirrhosis) and heart diseases.
The Dimension VistaTM Total Iron-binding capacity (TIBC) Flex® reagent cartridge is intended to quantitatively measure total iron binding capacity in human serum and plasma. Measurements of total iron binding capacity are used in the diagnosis and treatment of iron deficiency anemia and chronic inflammatory disorders.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K061020 · printed Nov 5, 2026
Cite this page
510(k) Report. “K061020: Dimension Vista Albumin, Alkaline Phosphatase, Aspartate Amino Transferase, Carbamazepine & Alanine Amino Transferase.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K061020
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026